Sophiris Bio Inc. Announces Election of Directors

/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/

SAN DIEGO, CA and VANCOUVER, June 14, 2013 /CNW/ - Sophiris Bio Inc. (TSX: SHS) (the "Company" or "Sophiris"), in accordance with Toronto Stock Exchange requirements, announced the voting results for the election of its Board of Directors at the Annual Meeting of Shareholders held on June 12, 2013 in Vancouver, British Columbia.  The director nominees, as listed in the Management Proxy Circular dated May 3, 2013, were elected as directors of the Company at the meeting.  The proxy votes submitted for each director were as follows:

       
  For       Withheld
Dr. Lars Ekman 85,131,509 99.99%   8,833 0.01%
Dr. John (Jack) Geltosky 85,131,509 99.99%   8,833 0.01%
Jim Heppell 85,031,509 99.87%   108,833 0.13%
Noah Knauf 85,131,509 99.99%   8,833 0.01%
William R. Rohn 85,131,509 99.99%   8,833 0.01%
Amit Sobti 85,133,509 99.99%   6,833 0.01%
Randall E. Woods 85,131,509 99.99%   8,833 0.01%
           

The results of the other matters considered at the meeting are reported in the Report of Voting Results as filed on SEDAR on June 14, 2013.

The Company's statutory filings are available at www.sedar.com.

About Sophiris Bio:
Sophiris Bio Inc. is a urology company developing a clinical-stage, targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a market with significant demand. Sophiris' lead candidate for BPH, PRX302, is designed to be as efficacious as pharmaceuticals, less invasive than surgical interventions, and without the sexual side effects seen with existing treatments. For more information, please visit www.sophirisbio.com.

 

SOURCE: Sophiris Bio, Inc.

For further information:

Lauren Glaser
Investor Relations
The Trout Group
646-378-2972
lglaser@troutgroup.com

James Beesley
Investor Relations 
Sequoia Partners
778-389-7715
james@sequoiapartners.ca

Michael Moore
Investor Relations
TMX Equicom Group 
619-467-7067
mmore@tmxequicom.com

Jason I. Spark
Media Relations
Canale Communications, Inc.
619-849-6005
jason@canalecomm.com

Profil de l'entreprise

Sophiris Bio, Inc.

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.